Literature DB >> 21663705

Dystonia.

Ailsa Snaith1, Derick Wade.   

Abstract

INTRODUCTION: Dystonia is usually a lifelong condition with persistent pain and disability. Focal dystonia affects a single part of the body; generalised dystonia can affect most or all of the body. It is more common in women, and some types of dystonia are more common in people of European Ashkenazi Jewish descent. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of drug treatments, surgical treatments, and physical treatments for focal, and for generalised dystonia? We searched: Medline, Embase, The Cochrane Library, and other important databases up to February 2011 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 15 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: acetylcholine release inhibitors (botulinum toxin), acupuncture, anticholinergic/antihistaminic drugs, anticonvulsants, atypical antipsychotic drugs, benzodiazepines, biofeedback, chiropractic manipulation, deep brain stimulation of thalamus and globus pallidus, dopaminergic agonists and antagonists, gamma-aminobutyric acid (GABA) analogues, microvascular decompression, muscle relaxants, myectomy, occupational therapy, osteopathy, pallidotomy, physiotherapy, selective peripheral denervation, serotonergic agonists and antagonists, speech therapy, and thalamotomy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21663705      PMCID: PMC3275299     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  31 in total

Review 1.  Dystonia: abnormal movements result from loss of inhibition.

Authors:  Mark Hallett
Journal:  Adv Neurol       Date:  2004

2.  Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.

Authors:  Eric J Pappert; Terry Germanson
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

3.  Epidemiology of dystonia in Rochester, Minnesota.

Authors:  J G Nutt; M D Muenter; L J Melton; A Aronson; L T Kurland
Journal:  Adv Neurol       Date:  1988

4.  Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population.

Authors:  N Risch; D de Leon; L Ozelius; P Kramer; L Almasy; B Singer; S Fahn; X Breakefield; S Bressman
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

5.  Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial.

Authors:  J W Brans; R Lindeboom; J W Snoek; M J Zwarts; T W van Weerden; E R Brunt; J J van Hilten; W van der Kamp; M H Prins; J D Speelman
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

6.  A prevalence study of primary dystonia in eight European countries.

Authors: 
Journal:  J Neurol       Date:  2000-10       Impact factor: 4.849

7.  Pallidal deep-brain stimulation in primary generalized or segmental dystonia.

Authors:  Andreas Kupsch; Reiner Benecke; Jörg Müller; Thomas Trottenberg; Gerd-Helge Schneider; Werner Poewe; Wilhelm Eisner; Alexander Wolters; Jan-Uwe Müller; Günther Deuschl; Marcus O Pinsker; Inger Marie Skogseid; Geir Ketil Roeste; Juliane Vollmer-Haase; Angela Brentrup; Martin Krause; Volker Tronnier; Alfons Schnitzler; Jürgen Voges; Guido Nikkhah; Jan Vesper; Markus Naumann; Jens Volkmann
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

8.  Abnormal associative plasticity of the human motor cortex in writer's cramp.

Authors:  Angelo Quartarone; Sergio Bagnato; Vincenzo Rizzo; Hartwig R Siebner; Vincenzo Dattola; Antonio Scalfari; Francesca Morgante; Fortunato Battaglia; Marcello Romano; Paolo Girlanda
Journal:  Brain       Date:  2003-09-23       Impact factor: 13.501

9.  Botulinum toxin treatment of spasmodic torticollis.

Authors:  T J Anderson; J Rivest; R Stell; M J Steiger; H Cohen; P D Thompson; C D Marsden
Journal:  J R Soc Med       Date:  1992-09       Impact factor: 5.344

10.  The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm.

Authors:  R Lindeboom; R De Haan; M Aramideh; J D Speelman
Journal:  Mov Disord       Date:  1995-07       Impact factor: 10.338

View more
  3 in total

1.  The role of the trigeminal sensory nuclear complex in the pathophysiology of craniocervical dystonia.

Authors:  Lynley Bradnam; Christine Barry
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

2.  Rate of Hanger Reflex Occurrence: Unexpected Head Rotation on Fronto-temporal Head Compression.

Authors:  Takashi Asahi; Michi Sato; Hiroyuki Kajimoto; Masaki Koh; Daina Kashiwazaki; Satoshi Kuroda
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-06-29       Impact factor: 1.742

Review 3.  Behavioural interventions for people living with adult-onset primary dystonia: a systematic review.

Authors:  C J Bernstein; D R Ellard; G Davies; E Hertenstein; N K Y Tang; M Underwood; H Sandhu
Journal:  BMC Neurol       Date:  2016-03-22       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.